Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in the tumor necrosis factor-alpha field

L Rink1, H Kirchner

  • 1Institute of Immunology and Transfusion Medicine, University of Lübeck School of Medicine, Germany.

International Archives of Allergy and Immunology
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma.

Stem cells and development·2004
Same author

Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial.

Annals of hematology·2004
Same author

[The German guideline clearing-project on bronchial asthma - part 2: recommendations and key topics for a national guideline on bronchial asthma].

Pneumologie (Stuttgart, Germany)·2004
Same author

Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004
Same author

Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.

Folia biologica·2003
Same author

[Assessment and implementation of guidelines].

Die Rehabilitation·2003

Tumor necrosis factor (TNF), a key cytokine, is crucial in various biological processes. Recent advancements focus on its gene, receptors, and roles in diseases like cancer and autoimmune conditions.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor (TNF), also known as TNF-alpha, is a pleiotropic cytokine with significant biological effects.
  • First described last century and discovered in 1975, TNF is now a major focus of scientific research across multiple disciplines.

Purpose of the Study:

  • To provide a concise review of the current state of knowledge regarding TNF.
  • To highlight recent advancements in TNF research over the past two years.

Main Methods:

  • Literature review focusing on gene organization, transcription, and polymorphism.
  • Analysis of TNF biochemistry and receptor interactions.
  • Examination of TNF's biological roles in various disease contexts and cellular functions.

Related Experiment Videos

Main Results:

  • Progress has been made in understanding TNF gene organization, transcription, and polymorphism.
  • New insights into TNF biochemistry and its receptors have emerged.
  • The biological significance of TNF in autoimmune diseases, infectious diseases, transplantation, cancer, and endothelial cell function has been further elucidated.

Conclusions:

  • TNF remains a critical cytokine with expanding research frontiers.
  • Recent findings deepen our understanding of TNF's complex roles in health and disease.
  • Continued investigation into TNF biology is essential for therapeutic advancements.